Chunxiao Li - Publications

Profiling peripheral MDSCs and Tregs in breast cancer: clinical significance and prediction of lymph node metastasis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 02, 2025

Dalpiciclib plus aromatase inhibitor versus neoadjuvant chemotherapy for ER-positive, HER2-negative breast cancer.

Journal: Frontiers in oncology

Published: January 24, 2025

The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: March 21, 2024

Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer.

Journal: Frontiers in oncology

Published: February 28, 2023

A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes combined with Ki-67 (RDBN-K).

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: December 14, 2021

Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis.

Journal: Scientific reports

Published: September 17, 2020

The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: July 14, 2018

Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.

Journal: Oncology reports

Published: May 28, 2016